Gabalex Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-60,000
| Closed | -$3.79M | – | 22 |
|
|
2021
Q1 | $3.79M | Sell |
60,000
-10,541
| -15% | -$665K | 1.91% | 20 |
|
|
2020
Q4 | $4.38M | Sell |
70,541
-129,459
| -65% | -$8.03M | 2.37% | 17 |
|
|
2020
Q3 | $12.1M | Hold |
200,000
| – | – | 3.37% | 14 |
|
|
2020
Q2 | $11.8M | Sell |
200,000
-25,000
| -11% | -$1.47M | 3.7% | 12 |
|
|
2020
Q1 | $12.5M | Buy |
225,000
+25,000
| +13% | +$1.39M | 4.32% | 10 |
|
|
2019
Q4 | $12.8M | Hold |
200,000
| – | – | 3.36% | 15 |
|
|
2019
Q3 | $10.1M | Buy |
200,000
+50,000
| +33% | +$2.54M | 2.74% | 16 |
|
|
2019
Q2 | $6.8M | Buy |
150,000
+25,000
| +20% | +$1.13M | 1.77% | 17 |
|
|
2019
Q1 | $5.96M | Buy |
+125,000
| New | +$5.96M | 1.72% | 17 |
|